“We are excited to add a strong emphasis on partnering to the expanded China Forum,” said Brett Johnson, Founder of OneMedForum. This development is the result of a joint venture between OneMedForum and The Pharma Partners of Hong Kong (TPP). TPP has selected 50 investment groups to a
Interface focuses on combinatioScreen Shot 2014-11-21 at 5.13.19 PMn products, most specifically for PICCs, ports, and catheters. Interface has developed an anti-thrombogenic device and a combination drug delivery device, which can be utilized in a range of clinical fields including c
Laparoscopic procedures conducted with the EndoSphere Surgical system are immensely easier, and can be done in an environment with significantly lowered pressure. Mr. Prenovitz described the new system as being easier for surgeons, especially those 45 and under – as they have played m
OneMedForum – for the first time – will offer a general exhibit area to showcase poster displays on all presenting companies as well as exhibits featuring new tools and technologies for emerging healthcare companies. Exhibits will focus on innovative solutions and will include equity
The 8th Annual OneMedForum reports new features for its January conference. In addition to a central and spacious venue at the Marriott Marquis, OneMedForum continues to develop some key programs to strengthen its capital raising platforms and business development.
OneMedForum announced that its 8th annual conference will move to the San Francisco Marriott Marquis, January 12-14, 2015. According to Brett Johnson, Founder and CEO, “This new venue is probably the most significant development in the nearly 8 years we’ve been doing the conference. I
NanoViricides, Inc. (NYSE MKT:NNVC) opened its new R&D and cGMP pilot manufacturing facility with U.S. Congressman Jim Himes performing the ribbon cutting to inaugurate the facility on July 21, 2014.
NanoViricides, Inc. is a development stage company that is creating special purpos
On May 21, 2014, the first OneMedMarket conference was held in New York City. Accredited investors turned out from all over for presentations from eleven CEOs of curated, candidate healthcare technology companies. The presentations were webcast to over a hun
However irksome it may be to think about open or healing wounds, the medical advances and market potential in this niche space is quite appealing for investors. Globally, there are 50 million reported cases of patients suffering from some type of wound that may be difficult to close o